Verruca vulgaris of tympanic membrane treated with topical immunotherapy

Verruca vulgaris is a common skin disease caused by human papillomavirus (HPV) infection, but it rarely involves the tympanic membrane. The current treatments for verruca are usually destructive and irreversible, should not be performed universally; the most relevant therapy will be variable subject to disease location, severity, and the patient's immune status. In this report, we demonstrated a case with verruca vulgaris of tympanic membrane, who had topical immunomodulatory agent treatment successfully with well-preserved hearing, and who has no any recurrence up to now for 3 years. In clinical, to cure verruca on the vulnerable tympanic membrane without hearing sequela is a dilemma, and there is no any treatment guideline due to its rarity. Topical immunomodulatory agent with high selectivity, showed great competence on this occasion and verified its practicability in treating verruca on unapproachable area, or where bearing vital functions; the convenient out-patient-based application also ensures good compliance. However, it does need longer duration and higher costs than the other routine treatment modalities.